VIKING GLOBAL INVESTORS LP Celldex Therapeutics, Inc. Transaction History

VIKING GLOBAL INVESTORS LP portfolio value:

$0
portfolio value

VIKING GLOBAL INVESTORS LP quarter portfolio value change:

+4.27%
quarter

Celldex Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -2.33M shares -63.02M $28.11 0
Q2 2022 share Increase +26.60% 491.20K shares 132K $26.96 2.33M
Q1 2022 share Increase +143.66% 1.08M shares 33.61M $34.06 1.84M
Q4 2021 share Decrease -0.58% -4.41K shares -11.87M $38.9 757.88K
Q3 2021 share Increase 0.00% 762.29K shares 41.15M $53.99 762.29K